Literature DB >> 31853951

Intestinal Absorption of Bile Acids in Health and Disease.

Alexander L Ticho1, Pooja Malhotra2, Pradeep K Dudeja2,3, Ravinder K Gill2, Waddah A Alrefai2,3.   

Abstract

The intestinal reclamation of bile acids is crucial for the maintenance of their enterohepatic circulation. The majority of bile acids are actively absorbed via specific transport proteins that are highly expressed in the distal ileum. The uptake of bile acids by intestinal epithelial cells modulates the activation of cytosolic and membrane receptors such as the farnesoid X receptor (FXR) and G protein-coupled bile acid receptor 1 (GPBAR1), which has a profound effect on hepatic synthesis of bile acids as well as glucose and lipid metabolism. Extensive research has focused on delineating the processes of bile acid absorption and determining the contribution of dysregulated ileal signaling in the development of intestinal and hepatic disorders. For example, a decrease in the levels of the bile acid-induced ileal hormone FGF15/19 is implicated in bile acid-induced diarrhea (BAD). Conversely, the increase in bile acid absorption with subsequent overload of bile acids could be involved in the pathophysiology of liver and metabolic disorders such as fatty liver diseases and type 2 diabetes mellitus. This review article will attempt to provide a comprehensive overview of the mechanisms involved in the intestinal handling of bile acids, the pathological implications of disrupted intestinal bile acid homeostasis, and the potential therapeutic targets for the treatment of bile acid-related disorders. Published 2020. Compr Physiol 10:21-56, 2020.
Copyright © 2019 American Physiological Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31853951      PMCID: PMC7171925          DOI: 10.1002/cphy.c190007

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  438 in total

1.  Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter.

Authors:  B L Shneider; P A Dawson; D M Christie; W Hardikar; M H Wong; F J Suchy
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

Review 2.  Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.

Authors:  John Y L Chiang; Preeti Pathak; Hailiang Liu; Ajay Donepudi; Jessica Ferrell; Shannon Boehme
Journal:  Dig Dis       Date:  2017-03-01       Impact factor: 2.404

3.  Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.

Authors:  Atsushi Nakajima; Mitsunori Seki; Shinya Taniguchi; Akira Ohta; Per-Göran Gillberg; Jan P Mattsson; Michael Camilleri
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-05-25

4.  Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.

Authors:  Anuradha Rao; Astrid Kosters; Jamie E Mells; Wujuan Zhang; Kenneth D R Setchell; Angelica M Amanso; Grace M Wynn; Tianlei Xu; Brad T Keller; Hong Yin; Sophia Banton; Dean P Jones; Hao Wu; Paul A Dawson; Saul J Karpen
Journal:  Sci Transl Med       Date:  2016-09-21       Impact factor: 17.956

5.  Bile acid uptake via the human apical sodium-bile acid cotransporter is electrogenic.

Authors:  S A Weinman; M W Carruth; P A Dawson
Journal:  J Biol Chem       Date:  1998-12-25       Impact factor: 5.157

6.  Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor alpha.

Authors:  Diana Jung; Michael Fried; Gerd A Kullak-Ublick
Journal:  J Biol Chem       Date:  2002-06-07       Impact factor: 5.157

7.  Conserved aspartic acid residues lining the extracellular loop 1 of sodium-coupled bile acid transporter ASBT Interact with Na+ and 7alpha-OH moieties on the ligand cholestane skeleton.

Authors:  Naissan Hussainzada; Tatiana Claro Da Silva; Eric Y Zhang; Peter W Swaan
Journal:  J Biol Chem       Date:  2008-05-28       Impact factor: 5.157

8.  Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism.

Authors:  Mary-Elizabeth Patti; Sander M Houten; Antonio C Bianco; Raquel Bernier; P Reed Larsen; Jens J Holst; Michael K Badman; Eleftheria Maratos-Flier; Edward C Mun; Jussi Pihlajamaki; Johan Auwerx; Allison B Goldfine
Journal:  Obesity (Silver Spring)       Date:  2009-04-09       Impact factor: 5.002

9.  Sphingosine-1 phosphate promotes intestinal epithelial cell proliferation via S1PR2.

Authors:  Tanzhou Chen; Zhiming Huang; Runping Liu; Jing Yang; Phillip B Hylemon; Huiping Zhou
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

10.  A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis.

Authors:  Melissa Palmer; Lee Jennings; Debra G Silberg; Caleb Bliss; Patrick Martin
Journal:  BMC Pharmacol Toxicol       Date:  2018-03-16       Impact factor: 2.483

View more
  30 in total

Review 1.  Intestinal secretory mechanisms and diarrhea.

Authors:  Stephen J Keely; Kim E Barrett
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-02-16       Impact factor: 4.052

2.  Nasobiliary drainage: an effective treatment for pruritus in cholestatic liver disease.

Authors:  Wafaa Ahmed; Rebecca Jeyaraj; David Reffitt; John Devlin; Abid Suddle; John Hunt; Michael A Heneghan; Phillip Harrison; Deepak Joshi
Journal:  Frontline Gastroenterol       Date:  2022-01-11

3.  Magnetic Resonance Cholangiopancreatography to Evaluate Improvement Effect of FXR Regulating Bile Acid on Hepatocellular Carcinoma with Obstructive Jaundice.

Authors:  Liu Wang; Shi Liu; Yuanyuan Li
Journal:  Contrast Media Mol Imaging       Date:  2022-06-23       Impact factor: 3.009

Review 4.  Gut homeostasis, injury, and healing: New therapeutic targets.

Authors:  Sema Oncel; Marc D Basson
Journal:  World J Gastroenterol       Date:  2022-05-07       Impact factor: 5.374

5.  NPC1L1-dependent transport of 27-alkyne cholesterol in intestinal epithelial cells.

Authors:  Alexander L Ticho; Nathan Calzadilla; Pooja Malhotra; Hyunjin Lee; Arivarasu Natarajan Anbazhagan; Seema Saksena; Pradeep K Dudeja; Daesung Lee; Ravinder K Gill; Waddah A Alrefai
Journal:  Am J Physiol Cell Physiol       Date:  2021-03-24       Impact factor: 4.249

6.  Characterization of cytoplasmic lipid droplets in each region of the small intestine of lean and diet-induced obese mice in response to dietary fat.

Authors:  Alyssa S Zembroski; Theresa D'Aquila; Kimberly K Buhman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-05-19       Impact factor: 4.871

Review 7.  Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gabriella Garruti; Mirco Vacca; Maria De Angelis; David Q-H Wang
Journal:  Nutrients       Date:  2020-11-30       Impact factor: 5.717

Review 8.  Lipidome is lipids regulator in gastrointestinal tract and it is a life collar in COVID-19: A review.

Authors:  Khaled Mohamed Mohamed Koriem
Journal:  World J Gastroenterol       Date:  2021-01-07       Impact factor: 5.742

9.  Astragalus Polysaccharides Ameliorate Diet-Induced Gallstone Formation by Modulating Synthesis of Bile Acids and the Gut Microbiota.

Authors:  Qian Zhuang; Xin Ye; Shuang Shen; Jinnian Cheng; Yan Shi; Shan Wu; Jie Xia; Min Ning; Zhixia Dong; Xinjian Wan
Journal:  Front Pharmacol       Date:  2021-07-01       Impact factor: 5.810

Review 10.  Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications.

Authors:  Yao Peng; Yuqiang Nie; Jun Yu; Chi Chun Wong
Journal:  Metabolites       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.